Corneal Ulcer
38
3
4
18
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
2.6%
1 terminated out of 38 trials
94.7%
+8.2% vs benchmark
21%
8 trials in Phase 3/4
44%
8 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (38)
Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis
Follow-up Compliance for Corneal Ulcer Patients With SMS Reminder
Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
Cross-linking for Corneal Ulcers Treatment Trial
Village Integrated Eye Workers Trial
Open-label Trial to Evaluate Efficacy and Safety of rhNGF on Corneal Thickness Via AS-OCT in Neurotrophic Keratitis
Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.
Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis
AONDA Therapeutic Indication Study I
Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy
ACRO Biocornea Clinical Trial in Taiwan
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers
Effect of Various Treatment Modalities on Dendritic Vial Ulcer
Improving the Follow up Rate for Pediatric Patients
Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3
Keratoconus, Corneal Diseases and Transplant Registry